Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Luminari

Showing results (121-130 of 210) with videos related to

Pageof 21
Sort By:
Haematologica|February 19, 2011
Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE projectRafael Marcos-Gragera, Claudia Allemani, Carmen Tereanu, et al.
Ecancermedicalscience|September 6, 2016
Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing groupStefano Botti, Laura Orlando, Gianpaolo Gargiulo, et al.
Blood Cancer Journal|October 16, 2025
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trialsSimonetta Viviani, Chiara Pavoni, Sally F Barrington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi TrialMassimo Federico, Stefano Luminari, Emilio Iannitto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II StudyArmando Santoro, Rita Mazza, Alessandro Pulsoni, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trialEmilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Haematologica|April 6, 2006
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's diseaseAndrea Gallamini, Luigi Rigacci, Francesco Merli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish studyAndrea Gallamini, Martin Hutchings, Luigi Rigacci, et al.
Leukemia & Lymphoma|May 16, 2017
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study<sup></sup>Tanya Skamene, Michael Crump, Kerry J Savage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana LinfomiMassimo Federico, Stefano Luminari, Alessandra Dondi, et al.
Pageof 21

Showing results (121-130 of 210) with videos related to

Sort By:
Pageof 21
Haematologica|February 19, 2011
Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE projectRafael Marcos-Gragera, Claudia Allemani, Carmen Tereanu, et al.
Ecancermedicalscience|September 6, 2016
Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing groupStefano Botti, Laura Orlando, Gianpaolo Gargiulo, et al.
Blood Cancer Journal|October 16, 2025
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trialsSimonetta Viviani, Chiara Pavoni, Sally F Barrington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi TrialMassimo Federico, Stefano Luminari, Emilio Iannitto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II StudyArmando Santoro, Rita Mazza, Alessandro Pulsoni, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trialEmilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Haematologica|April 6, 2006
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's diseaseAndrea Gallamini, Luigi Rigacci, Francesco Merli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish studyAndrea Gallamini, Martin Hutchings, Luigi Rigacci, et al.
Leukemia & Lymphoma|May 16, 2017
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study<sup></sup>Tanya Skamene, Michael Crump, Kerry J Savage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana LinfomiMassimo Federico, Stefano Luminari, Alessandra Dondi, et al.
Pageof 21